Geron (GERN) Current Leases (2019 - 2026)
Geron (GERN) posted Current Leases of $1.0 million for Q1 2026, up 0.7% sequentially from $1.0 million in Q4 2025, and up 2.65% YoY from $981000.0 in Q1 2025.
Geron (GERN) Current Leases (2019 - 2026) Analysis & Trends
Geron has reported Current Leases for 8 years, with the latest figure at $1.0 million in Q1 2026.
- Quarterly Current Leases rose 2.65% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 2.65% YoY) and the FY2025 annual result came in at $1.0 million, up 2.67% from the prior year.
- Current Leases climbed to $1.0 million in Q1 2026 per GERN's latest filing, from $1.0 million in the prior quarter.
- Over five years, Current Leases peaked at $1.0 million in Q1 2026 and troughed at $786000.0 in Q2 2023.
- A 5-year average of $947058.8 and a median of $955000.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases retreated 13.91% in 2023, then grew 22.26% in 2024.
- Over 5 years, Current Leases stood at $925000.0 in 2022, then increased by 2.59% to $949000.0 in 2023, then gained by 2.63% to $974000.0 in 2024, then rose by 2.67% to $1.0 million in 2025, then advanced by 0.7% to $1.0 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.0 million, $1.0 million, and $994000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Geron | 1.04 Mn | -299.81 Mn | - | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 994,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | 981,000.00 |
| Dec 31, 2024 | 974,000.00 |
| Sep 30, 2024 | 968,000.00 |
| Jun 30, 2024 | 961,000.00 |
| Mar 31, 2024 | 955,000.00 |
| Dec 31, 2023 | 949,000.00 |
| Sep 30, 2023 | 943,000.00 |
| Jun 30, 2023 | 786,000.00 |
| Mar 31, 2023 | 931,000.00 |
| Dec 31, 2022 | 925,000.00 |
| Sep 30, 2022 | 919,000.00 |
| Jun 30, 2022 | 913,000.00 |
| Mar 31, 2022 | 907,000.00 |
| Dec 31, 2021 | 901,000.00 |
| Sep 30, 2021 | 895,000.00 |